Pemafibrate may improve liver fibrosis, lipid metabolism and liver enzyme levels, according to results of a retrospective study of magnetic resonance elastrography (MRE) in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and hypertriglyceridaemia (HTG).1
